Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Petros Pharmaceuticals, Inc. (PTPI) had Return on Tangible Equity of -11.72% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.60M |
|
-- |
|
-- |
|
$0.39M |
|
$-0.39M |
|
$0.06M |
|
$-0.34M |
|
$-0.34M |
|
$-0.34M |
|
$-0.34M |
|
$-6.75M |
|
$-0.34M |
|
$-0.39M |
|
$-0.39M |
|
28.07M |
|
28.07M |
|
$9.13 |
|
$9.13 |
|
| Balance Sheet Financials | |
$5.16M |
|
-- |
|
-- |
|
$5.16M |
|
$2.29M |
|
-- |
|
-- |
|
$2.29M |
|
$2.87M |
|
$2.87M |
|
$2.87M |
|
42.28M |
|
| Cash Flow Statement Financials | |
$-6.73M |
|
-- |
|
$8.16M |
|
$3.71M |
|
$5.14M |
|
$1.43M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.72% |
|
|
Return on Tangible Equity |
-11.72% |
-6.52% |
|
-11.72% |
|
$0.07 |
|
$-0.24 |
|
$-0.24 |
|